Skip to content
logo
  • Home
  • About
    OverviewMeet the TeamPrimeVigilanceMedSource
  • CRO
    OverviewOrphan Drug DevelopmentTherapeutic ExpertiseClinical Expertise: Phase I–IVSite Support ServicesCOVID-19CRO Publications and Resources
  • Investors
    Investor RelationsReports and PresentationsShareholder Communications
  • News and Events
    OverviewRegulatory News
  • Careers
  • Contact
  • Legal Information
  • Privacy & Cookie Policies
  • Sitemap

Shareholder Communications

Filter By:

All

Proposed Reduction of Capital and Notice of General Meeting

01 Oct 2020

Download

Form of Proxy – General Meeting 2020

01 Oct 2020

Download

Proposed Acquisition of Haemostatix Ltd, Placing and Notice of General Meeting

05 May 2016

Download

Letter to Shareholders regarding resignation of Deloitte LLP as Auditor of Ergomed PLC

11 Jul 2018

Download

Investor Relations

Read more

Regulatory News

Read more

United Kingdom

1 Occam Court
Surrey Research Park
Guildford, Surrey
GU2 7HJ

Please send general enquiries to: info@ergomedplc.com

Quick Links

  • CRO Publications and Resources
  • Investor Relations
  • News and Events
  • About Us
  • Careers
  • PrimeVigilance
  • Contact Us
logo
© Ergomed Plc 2017 - 2021
  • Anti-Slavery and Human Trafficking Statement
  • Legal Information
  • Privacy & Cookie Policies
  • Sitemap